A 42-year-old man with a history of peptic ulcer disease is given a muscarinic antagonist for symptom relief. His colleague asks: 'Why does this drug block gastric acid secretion, whereas a β-blocker would not?' Which second-messenger pathway best explains this difference?

Explanation

## Gastric Acid Secretion: Acetylcholine vs. Histamine Signaling ### Acetylcholine (Muscarinic M3) Pathway **Key Point:** Acetylcholine binds M3 receptors (Gq-coupled GPCR) on parietal cells → activates phospholipase C (PLC) → generates IP3 (inositol 1,4,5-trisphosphate) and DAG (diacylglycerol) → IP3 releases Ca²⁺ from intracellular stores → Ca²⁺-calmodulin activates myosin light-chain kinase and other effectors → **strong stimulation of H⁺-ATPase** and acid secretion. ### Histamine (H2) Pathway **Key Point:** Histamine binds H2 receptors (Gs-coupled GPCR) on parietal cells → activates adenylyl cyclase → ↑ cAMP → PKA activation → phosphorylates CREB and other substrates → acid secretion (but weaker than acetylcholine or gastrin). ### Comparison Table | Feature | Acetylcholine (M3) | Histamine (H2) | | --- | --- | --- | | Receptor type | Gq-coupled GPCR | Gs-coupled GPCR | | Second messenger | IP3 + DAG | cAMP | | Primary effect | ↑ Intracellular Ca²⁺ | ↑ cAMP → PKA | | Acid secretion strength | **Strongest** | Moderate | | Blocked by | Muscarinic antagonists (e.g., atropine) | H2-blockers (e.g., ranitidine) | | β-blocker effect | No effect (not adrenergic) | No effect (H2 ≠ β-adrenergic) | ### Why Muscarinic Antagonist Works **High-Yield:** Acetylcholine is the **most potent** stimulus for gastric acid secretion. Blocking its IP3/DAG pathway (via M3 antagonism) prevents the rise in intracellular Ca²⁺, which is essential for parietal cell activation. β-blockers do not work because gastric parietal cells do not have significant β-adrenergic receptors; they respond to acetylcholine, histamine, and gastrin. **Mnemonic:** **ACh-IP3-Ca²⁺** (Acetylcholine → IP3 → Calcium = strongest acid stimulus); **His-cAMP** (Histamine → cAMP = weaker). ### Clinical Pearl Histamine, acetylcholine, and gastrin all stimulate acid secretion, but via different pathways. Proton pump inhibitors (omeprazole) block the final common pathway (H⁺-ATPase) and are most effective; H2-blockers block histamine; muscarinic antagonists block acetylcholine. Combination therapy may be more effective than monotherapy.